HealthCap
Stockholm, Stockholm Countyhealthcap.eu
Overview
HealthCap is a European venture capital firm investing globally in life sciences. The firm has raised eight funds since 1996 and has backed and built more than 130 companies, taken more than 45 companies public, and completed numerous trade sales. HealthCap's investment strategy focuses on diseases with a high unmet medical need and breakthrough therapies that have the potential to be transformative, change clinical practice, and change the lives of patients suffering from these conditions.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Adcendo | Apr 2026 | Series C | Co-investor |
| Hemab Therapeutics | Oct 2025 | Series C | Co-investor |
| Hemab | Oct 2025 | Series C | Co-investor |
| Gesynta Pharma AB | Jul 2025 | Series B | Co-investor |
| Tribune Therapeutics | Mar 2025 | Series A | Co-investor |
Key People
Marten Steen
Managing Partner
Georg Vo Beiske
Venture Partner
Anki Forsberg
Partner
Björn Odlander
Partner
Carl Kilander
Partner
Max Odlander
Partner
Per Samuelsson
Partner
Staffan Lindstrand
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
